The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125454712 12545471 2 F 20160505 20160708 20160711 20160715 EXP BR-PFIZER INC-2016335688 PFIZER 77.00 YR F Y 0.00000 20160715 PH BR BR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125454712 12545471 1 PS LINEZOLID. LINEZOLID 1 Intravenous (not otherwise specified) 600 MG, EVERY 12 HOURS Y SET15-U26 21131 600 MG SOLUTION FOR INFUSION BID
125454712 12545471 2 SS PIPERACILLIN/TAZOBACTAM PIPERACILLIN SODIUMTAZOBACTAM SODIUM 1 Intravenous (not otherwise specified) 4.5 G, EVERY 8 HOURS Y 50684 4.5 G INJECTION TID
125454712 12545471 3 SS TEICOPLANIN TEICOPLANIN 1 400 MG, 1X/DAY 4800 MG 0 400 MG QD
125454712 12545471 4 SS CEFTAZIDIME. CEFTAZIDIME 1 2 G, EVERY 8 HOURS 72 G 0 2 G TID
125454712 12545471 5 SS VANCOMYCIN VANCOMYCIN 1 1 G, EVERY 12 HOURS 34 G Y 0 1 G BID
125454712 12545471 6 SS RIFAMPICIN RIFAMPIN 1 300 MG, EVERY 12 HOURS 10200 MG Y 0 300 MG BID
125454712 12545471 7 SS MEROPENEM. MEROPENEM 1 1 G, EVERY 8 HOURS 9 G Y 0 1 G TID
125454712 12545471 8 SS CIPROFLOXACIN. CIPROFLOXACIN 1 Intravenous (not otherwise specified) 400 MG, EVERY 12 HOURS Y 0 400 MG INJECTION BID
125454712 12545471 9 SS AMIKACIN AMIKACIN 1 Intravenous (not otherwise specified) 500 MG, EVERY 12 HOURS Y 0 500 MG INJECTION BID
125454712 12545471 10 SS CEFUROXIME. CEFUROXIME 1 1.5 MG, EVERY 12 HOURS 12 MG 0 1.5 MG BID
125454712 12545471 11 SS HYDRALAZINE HYDRALAZINE HYDROCHLORIDE 1 Y 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125454712 12545471 1 Enterobacter infection

Outcome of event

Event ID CASEID OUTC COD
125454712 12545471 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125454712 12545471 Bone marrow toxicity
125454712 12545471 Bronchospasm
125454712 12545471 Chest pain
125454712 12545471 Dyspnoea
125454712 12545471 Erythema
125454712 12545471 Headache
125454712 12545471 Hyperaemia
125454712 12545471 Hypersensitivity
125454712 12545471 Hypertensive crisis
125454712 12545471 Malaise
125454712 12545471 Pancytopenia
125454712 12545471 Pruritus
125454712 12545471 Pyrexia
125454712 12545471 Rash
125454712 12545471 Respiratory distress
125454712 12545471 Skin burning sensation
125454712 12545471 Suffocation feeling
125454712 12545471 Swelling
125454712 12545471 Swollen tongue
125454712 12545471 Throat irritation
125454712 12545471 Tongue dry
125454712 12545471 Wheezing

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125454712 12545471 1 20160620 20160629 0
125454712 12545471 2 20160615 20160624 0
125454712 12545471 3 20160519 20160530 0
125454712 12545471 4 20160519 20160530 0
125454712 12545471 5 20160530 20160620 0
125454712 12545471 6 20160530 20160620 0
125454712 12545471 7 20160613 20160615 0
125454712 12545471 8 20160615 20160616 0
125454712 12545471 9 20160624 20160625 0
125454712 12545471 10 20160502 20160505 0